Division of Urology, Department of Surgery, The Chinese University of Hong Kong, 4/F Prince of Wales Hospital, Shatin, New Territories, Hong Kong, SAR, China,
Int Urol Nephrol. 2013 Oct;45(5):1245-51. doi: 10.1007/s11255-013-0501-4. Epub 2013 Jul 18.
To evaluate the outcomes of augmentation cystoplasty in patients with bladder contractures secondary to chronic ketamine abuse.
Patients who had received augmentation cystoplasty to treat ketamine-related bladder contractures in two hospitals in our region were reviewed retrospectively. Their history of ketamine consumption, presenting symptoms, history of treatment, surgical information and post-operative conditions were retrieved from clinical records and then summarized.
Between 2006 and 2011, four patients (three women and one man), aged 21-30 years (mean 27 years), underwent augmentation cystoplasty for ketamine-related bladder contractures. The duration of ketamine consumption ranged from 3 to 15 years, and all four patients resumed ketamine consumption after surgery. The mean maximal baseline and post-operative bladder capacity was 37.5 cc (range 25-50 cc) and up to 400-500 cc, respectively. Three patients experienced a further deterioration in renal function that was secondary to new-onset ureteral strictures in two cases and to sepsis in the other. At the time of the last follow-up, three patients could void spontaneously and one required regular intermittent catheterization.
Ketamine cystitis is an emerging medical condition that requires a multi-disciplinary approach to manage the patients. Simple surgical management of the physical component of the contracted bladder may produce only suboptimal results, and could even cause further problems in some patients. The importance of compliance with post-operative care and abstinence from drug use should be stressed to the patients before surgery. In view of the high complication rate, the option of a simple ileal conduit should also be discussed prior to surgical intervention.
评估慢性氯胺酮滥用继发膀胱挛缩患者行膀胱扩大术的治疗效果。
回顾性分析本地区 2 家医院收治的因氯胺酮相关性膀胱挛缩行膀胱扩大术的患者,收集其氯胺酮使用史、临床表现、治疗史、手术信息及术后情况等资料并进行总结。
2006 年至 2011 年间,4 例(3 女 1 男)年龄 2130 岁(平均 27 岁)患者因氯胺酮相关性膀胱挛缩接受了膀胱扩大术。氯胺酮使用时间为 315 年,所有患者术后均恢复氯胺酮使用。最大基线和术后膀胱容量分别为 37.5cc(2550cc)和 400500cc。3 例患者肾功能进一步恶化,其中 2 例为新发输尿管狭窄,1 例为脓毒症。末次随访时,3 例患者可自主排尿,1 例需定期间歇性导尿。
氯胺酮性膀胱炎是一种新兴的医疗状况,需要多学科方法来管理患者。单纯手术治疗挛缩膀胱的物理因素可能只能产生不理想的结果,甚至可能导致某些患者出现进一步的问题。在手术前应向患者强调遵守术后护理和戒除药物使用的重要性。鉴于高并发症发生率,在手术干预前还应讨论简单的回肠导管的选择。